![Karin Walker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karin Walker
Comptroller/Controller/Auditor at
PROTHENA CORPORATION PLC
Net worth: 93 500 $ as of 30/08/2026
Profile
Karin L.
Walker currently works at Prothena Corp.
Plc, as Chief Accounting Officer.
Ms. Walker also formerly worked at LifeSci Acquisition Corp., as Independent Directors in 2020, Cyclacel Pharmaceuticals, Inc., as Independent Non-Executive Director from 2020 to 2025, Affymax, Inc., as Chief Accounting Officer & Vice President-Finance from 2012 to 2013, Ernst & Young US LLP, as Accountant, CV Therapeutics, Inc., as Vice President-Finance & Controller from 2006 to 2009, and Amyris, Inc., as Vice President-Finance & Controller from 2009 to 2012.
Ms. Walker received her undergraduate degree from California Polytechnic State University (San Luis Obispo).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PROTHENA CORP. PLC 0.02% | 27/07/2026 | 10,000 ( 0.02% ) | 93 500 $ | 30/08/2026 |
Karin Walker active positions
| Companies | Position | Start |
|---|---|---|
| PROTHENA CORPORATION PLC | Comptroller/Controller/Auditor | 19/05/2013 |
Former positions of Karin Walker
| Companies | Position | End |
|---|---|---|
| BIO GREEN MED SOLUTION, INC. | Director/Board Member | 02/01/2025 |
| VINCERX PHARMA, INC. | Director/Board Member | 22/12/2020 |
| AFFYMAX, INC. | Comptroller/Controller/Auditor | 30/04/2013 |
| AMYRIS, INC. | Comptroller/Controller/Auditor | 31/08/2012 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Comptroller/Controller/Auditor | 31/07/2009 |
Training of Karin Walker
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
59
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Amyris, Inc.
 Amyris, Inc. Chemicals: SpecialtyProcess Industries Operates as a biomanufacturing company that uses renewable biological chemistry | Process Industries |
Affymax, Inc.
 Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
California Polytechnic State University (San Luis Obispo)
 California Polytechnic State University (San Luis Obispo) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cyclacel Pharmaceuticals, Inc.
 Cyclacel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes mechanism-targeted drugs to treat human cancers | Health Technology |
Prothena Corp. Plc
 Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
Ernst & Young US LLP
 Ernst & Young US LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
LifeSci Acquisition Corp.
 LifeSci Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Stock Market
- Insiders
- Karin Walker
